A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...

Treatment options for prostate cancer have dramatically expanded. Facing a prostate cancer diagnosis often raises concerns among men and their partners: will treatment affect intimacy and their ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

Prostate health remains a crucial topic that many men avoid discussing, even with close family members. Early screenings can make a significant difference in detecting issues before they become severe ...

Screening men for prostate cancer through a blood test is likely to cut deaths from the condition, a new review has discovered. The results of the analysis, which encompassed nearly 800,000 patients, ...

Frequent night-time bathroom trips, a weak flow and other common symptoms are often dismissed as ageing. Experts explain what ...